• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?司库奇尤单抗治疗的银屑病患者发生2019冠状病毒病（COVID-19）皮疹：白细胞介素17起作用吗？
Dermatol Ther. 2020 Nov;33(6):e14011. doi: 10.1111/dth.14011. Epub 2020 Jul 27.
2
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.在使用司库奇尤单抗治疗无效的银屑病患者中转换为使用依奇珠单抗的疗效和安全性：一项多中心研究结果
Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21.
3
Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients.度普利尤单抗治疗特应性皮炎：SARS-CoV-2感染患者的方案
Dermatol Ther. 2020 Nov;33(6):e14172. doi: 10.1111/dth.14172. Epub 2020 Sep 5.
4
Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.一名正在接受司库奇尤单抗治疗的银屑病患者合并慢性阻塞性肺疾病，感染新型冠状病毒肺炎2019。
Dermatol Ther. 2020 Nov;33(6):e14186. doi: 10.1111/dth.14186. Epub 2020 Sep 8.
5
Brodalumab-associated generalized eczematous eruption in a difficult-to-treat psoriasis patient: management without brodalumab withdrawal.一例难治性银屑病患者中与布罗达单抗相关的全身性湿疹样皮疹：未停用布罗达单抗的处理
Eur J Dermatol. 2020 Dec 1;30(6):741-743. doi: 10.1684/ejd.2020.3910.
6
Real-world efficacy and safety of interleukin-17 inhibitors for psoriasis: A single-center experience.真实世界中白细胞介素-17 抑制剂治疗银屑病的疗效和安全性：一项单中心经验。
J Dermatol. 2020 Apr;47(4):405-408. doi: 10.1111/1346-8138.15247. Epub 2020 Jan 28.
7
Effective treatment with guselkumab for psoriatic alopecia as paradoxical reaction.古塞库单抗治疗银屑病性脱发出现矛盾反应的有效治疗
J Dermatol. 2019 Aug;46(8):e302-e303. doi: 10.1111/1346-8138.14842. Epub 2019 Mar 12.
8
Efficacy and safety of secukinumab in a psoriatic patient affected by comorbid metabolic disorders.司库奇尤单抗治疗合并代谢性疾病的银屑病患者的疗效和安全性。
Dermatol Ther. 2019 May;32(3):e12858. doi: 10.1111/dth.12858. Epub 2019 Feb 28.
9
Secukinumab-induced paradoxical hidradenitis suppurativa.司库奇尤单抗诱导的化脓性汗腺炎。
Dermatol Ther. 2020 Jan;33(1):e13150. doi: 10.1111/dth.13150. Epub 2019 Nov 12.
10
Effect of Body Weight on Risk-Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis.体重对司库奇尤单抗治疗中度至重度斑块状银屑病的风险效益及给药方案推荐的影响
Clin Pharmacol Ther. 2019 Jul;106(1):78-80. doi: 10.1002/cpt.1478. Epub 2019 Jun 12.

引用本文的文献

1
Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.银屑病患者接受白细胞介素-17 抑制剂治疗后感染 COVID-19、住院和死亡的风险：系统评价和荟萃分析。
Front Immunol. 2022 Oct 21;13:1046352. doi: 10.3389/fimmu.2022.1046352. eCollection 2022.
2
Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade.严重急性呼吸综合征冠状病毒2感染：白细胞介素-6及炎症级联反应的作用
World J Virol. 2022 May 25;11(3):113-128. doi: 10.5501/wjv.v11.i3.113.
3
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.新冠病毒的免疫特征：细胞因子风暴的深入原因及后果。
Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545.
4
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.新冠疫情期间接受生物制剂治疗的银屑病和化脓性汗腺炎患者的皮肤表现
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
5
COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology.COVID-19 与眼科免疫调节剂的应用。
Turk J Ophthalmol. 2021 Aug 27;51(4):231-242. doi: 10.4274/tjo.galenos.2021.68252.
6
COVID-19 and exacerbation of dermatological diseases: A review of the available literature.COVID-19 与皮肤疾病恶化：现有文献综述。
Dermatol Ther. 2021 Nov;34(6):e15113. doi: 10.1111/dth.15113. Epub 2021 Sep 7.
7
The signal pathways and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的信号通路与治疗策略。
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0.
8
Skin Manifestation of SARS-CoV-2: The Italian Experience.新型冠状病毒肺炎的皮肤表现：意大利的经验
J Clin Med. 2021 Apr 8;10(8):1566. doi: 10.3390/jcm10081566.
9
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.接受系统治疗的中度至重度斑块状银屑病患者感染新冠疫情的风险
Vaccines (Basel). 2020 Dec 2;8(4):728. doi: 10.3390/vaccines8040728.

本文引用的文献

1
Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.揭开新冠病毒细胞因子风暴之谜：从皮肤到器官系统。
Dermatol Ther. 2020 Nov;33(6):e13859. doi: 10.1111/dth.13859. Epub 2020 Jul 7.
2
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
3
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.COVID-19 的皮肤表现：三例病例报告及文献复习。
J Dermatol Sci. 2020 May;98(2):75-81. doi: 10.1016/j.jdermsci.2020.04.011. Epub 2020 Apr 29.
4
COVID-19: a case for inhibiting IL-17?COVID-19：抑制白细胞介素-17（IL-17）的理由？
Nat Rev Immunol. 2020 Jun;20(6):345-346. doi: 10.1038/s41577-020-0328-z.
5
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.新型冠状病毒肺炎（COVID-19）与银屑病的生物治疗：不确定时期的感染风险及患者咨询
Dermatol Ther (Heidelb). 2020 Apr 16;10(3):339-349. doi: 10.1007/s13555-020-00377-9. eCollection 2020 Jun.
6
Covid-19: risk factors for severe disease and death.新冠病毒病：重症和死亡的风险因素
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
7
Should patients stop their biologic treatment during the COVID-19 pandemic.在新冠疫情期间，患者是否应该停止生物制剂治疗？
J Dermatolog Treat. 2020 Jun;31(4):317-318. doi: 10.1080/09546634.2020.1742438. Epub 2020 Mar 19.
8
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.降低2019新型冠状病毒所致死亡率：宿主导向疗法应成为一种选择。
Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.
9
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.实时 RT-PCR 检测 2019 新型冠状病毒（2019-nCoV）
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.

Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?

作者信息

Carugno Andrea, Gambini Daniele Mario, Raponi Francesca, Vezzoli Pamela, Robustelli Test Elisa, Arosio Marco Enrico Giovanni, Callegaro Annapaola, Sena Paolo

机构信息

Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.

Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

出版信息

Dermatol Ther. 2020 Nov;33(6):e14011. doi: 10.1111/dth.14011. Epub 2020 Jul 27.

DOI:10.1111/dth.14011
PMID:32654404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7404332/
Abstract
摘要